| NCT ID | NCT04947098 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Prisma Health-Upstate |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2018-11-08 |
| Primary Completion | 2028-11-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2018-11-08 with a primary completion date of 2028-11-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prevent Cancer-Greenville was created to provide individuals with the opportunity to have their risk of developing cancer studied. Some individuals may be at a higher risk due to their personal lifestyle, family history and/or exposures. If subjects are found to be at high risk for developing a disease, they will be sent to a healthcare provider for further care.
Eligibility Criteria
Inclusion Criteria: * 18 years or older
Contact & Investigator
Joe Stephenson, MD
PRINCIPAL INVESTIGATOR
Prisma Health-Upstate
Frequently Asked Questions
Who can join the NCT04947098 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04947098 currently recruiting?
Yes, NCT04947098 is actively recruiting participants. Contact the research team at ccpw@prismahealth.org for enrollment information.
Where is the NCT04947098 trial being conducted?
This trial is being conducted at Greenville, United States.
Who is sponsoring the NCT04947098 clinical trial?
NCT04947098 is sponsored by Prisma Health-Upstate. The principal investigator is Joe Stephenson, MD at Prisma Health-Upstate. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.